TNFRSF14 / CD270 / HVEM Monoclonal Antibody LS-C41150 from LSBio | Biocompare.com

Supplier Images

TNFRSF14 / CD270 / HVEM Monoclonal Antibody

Be the first to write a review!

Citations:

Supplier Page from
LSBio for
TNFRSF14 / CD270 / HVEM Monoclonal Antibody

LSBio's TNFRSF14 / CD270 / HVEM Monoclonal Antibody is a Mouse monoclonal antibody. The TNFRSF14 / CD270 / HVEM Monoclonal Antibody was generated using TNFRSF14 as the antigen. It reacts with Homo Sapiens, and Human. This antibody has been shown to work in applications such as: EIA, Immunoassay, ELISA, Flow Cytometry, and Western Blot.

Product Specs
ItemTNFRSF14 / CD270 / HVEM Monoclonal Antibody
CompanyLSBio
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberLS-C41150
NCBI Gene AliasesATAR, CD270, HVEA, HVEM, LIGHTR, TR2
PurityAffinity purified
ApplicationsELISA, Flo, WB
FormatPhosphate-buffered solution, pH 7.2, 0.09% sodium azide
IsotypeIgG1
ReactivityHuman
TargetTNFRSF14 / CD270 / HVEM
HostMouse
Conjugate/TagUnconjugated
Clone122
NCBI Full Gene NameTNF receptor superfamily member 14
ClonalityMonoclonal
Quantity100 µg

Specifications/Features

Specificity: Recombinant human HVEM protein

Add to Compare List

LSBio

LSBio

2 Shaker Road, Unit B101

Shirley, MA 01464

United States

Phone: 206-374-1102
Fax: 206-464-1723

Company Profile

Website: http://www.lsbio.com/

(1) Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancerBloodAugust 16, 2012Ramsay AG, Clear AJ, Fatah R, Gribben JG.

(2) B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantationJournal of immunology (Baltimore, Md. : 1950)July 1, 2012Hobo W, Norde WJ, Schaap N, Fredrix H, Maas F, Schellens K, Falkenburg JH, Korman AJ, Olive D, van der Voort R, et al.

(3) Polymorphic variants of LIGHT (TNF superfamily-14) alter receptor avidity and bioavailabilityJournal of immunology (Baltimore, Md. : 1950)August 1, 2010Cheung TC, Coppieters K, Sanjo H, Oborne LM, Norris PS, Coddington A, Granger SW, Elewaut D, Ware CF.

Be the First to Write a Review!